CLOUES EDWARD B II
Known title: DirectorCIK: 0001145949
CLOUES EDWARD B II's purchase track record
How the stock did after each of CLOUES EDWARD B II's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
9
of 9 since September 24, 2021
Stock higher 6 months later
56%
3 months: 56%
Median 6-month return
+10.9%
3 months: +1.8%
Beat the S&P 500
67%
median +8.7% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/21/2023 | AXR | $15K | +28.2% | +10.9% | +2.2% |
| 3/16/2023 | AXR | $12K | +32.1% | +46.6% | +13.8% |
| 12/16/2022 | AXR | $18K | +12.0% | +46.7% | +14.5% |
| 10/13/2022 | AXR | $11K | +1.8% | +29.6% | +13.0% |
| 9/22/2022 | AXR | $56K | -1.1% | +16.6% | +5.1% |
| 4/19/2022 | AXR | $50K | -6.7% | -11.4% | -16.6% |
| 1/4/2022 | AXR | $23K | -14.0% | -24.1% | -20.1% |
| 10/26/2021 | AXR | $29K | -7.0% | -12.7% | -8.7% |
| 9/24/2021 | AXR | $15K | +11.6% | -23.5% | +2.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AXR | ▲ Buy | Open Market | 1,000 | $15K | 4/21/2023 | View on chart |
| AXR | ▲ Buy | Open Market | 1,000 | $12K | 3/16/2023 | View on chart |
| AXR | ▲ Buy | Open Market | 1,500 | $18K | 12/16/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 1,000 | $11K | 10/13/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 250 | $3K | 9/27/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 1,500 | $17K | 9/26/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 1,009 | $12K | 9/23/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 2,000 | $24K | 9/22/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 1,500 | $19K | 4/21/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 2,500 | $31K | 4/19/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 1,551 | $23K | 1/4/2022 | View on chart |
| AXR | ▲ Buy | Open Market | 750 | $11K | 10/26/2021 | View on chart |
| AXR | ▲ Buy | Open Market | 1,200 | $18K | 10/26/2021 | View on chart |
| AXR | ▲ Buy | Open Market | 1,000 | $15K | 9/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
AMREP Target Cut to $22.44 by Consensus
Analysts have lowered their consensus price target for AMREP to $22.44, a 15.38% drop from the previous estimate. The new target sits just below the current support level of $22.77, which has been tested nine times. The change signals a shift in expectations for the company’s near‑term performance.
AMREP Target Cut to $22.44 by Consensus. Analysts have lowered their consensus price target for AMREP to $22.44, a 15.38% drop from the previous estimate. The new target sits just below the current support level of $22.77, which has been tested nine times. The change signals a shift in expectations for the company’s near‑term performance.